Home
Dashboard
Curated content
Startups & Scaleups
Corporates
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
Service providers
More organizations
Matching tool
Investment heatmap
Themes
News
Companies
InvaGen Pharmaceuticals
Save
InvaGen Pharmaceuticals
Fast growing generic pharmaceutical company.
Launch date
2003
Employees
51-200 people
Market cap
-
Enterprise valuation
€455m
(Public information from Sep 2015)
Town of Smithtown New York (HQ)
http://invagen.com
https://www.linkedin.com/company/cipla-usa/
B2B
manufacturing
health
marketing
crm & sales
biotechnology
biotech and pharma
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
InvaGen Pharmaceuticals funding
InvaGen Pharmaceuticals investors
Edit
Date
Investors
Amount
Round
Sep 2015
Cipla
$500m
Valuation: $500m
Acquisition
Total Funding
-
Related Content
Recent News about InvaGen Pharmaceuticals
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access